CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
"Armored" immune cells take on tough blood cancers in early trial
Disease control OngoingThis early-phase study tests the safety of a special type of immune cell, called an "armored" CAR T-cell, in people with certain blood cancers (like CLL) that have not responded to standard treatments. The cells are made from the patient's own blood and are designed to better att…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:52 UTC
-
CLL patients may pause treatment: new study explores drug-free remission
Disease control OngoingThis study looks at whether people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have no detectable cancer after taking venetoclax can safely stop the drug. Researchers will monitor 81 participants for at least 12 months to see how many remain ca…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New triple therapy shows promise for First-Line CLL treatment
Disease control OngoingThis study tests a combination of three drugs (acalabrutinib, venetoclax, and obinutuzumab) as an initial treatment for people with chronic lymphocytic leukemia (CLL) who have not had prior therapy. The goal is to see if this drug cocktail can wipe out cancer cells deep in the bo…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for CLL patients: drug duo targets leukemia without prior treatment
Disease control OngoingThis study tests a combination of two drugs, venetoclax and obinutuzumab, in people with chronic lymphocytic leukemia (CLL) who have not had any previous treatment. The goal is to see how well this therapy controls the disease and delays its progression. About 100 fit adults with…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:02 UTC